| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $237K | +18.3% | — |
| Cost of Revenue | $45K | -0.0% | — |
| Gross Profit | $192K | +23.6% | — |
| R&D Expense | $587K | +102.3% | -27.7% |
| SG&A Expense | $201K | -61.8% | +16.2% |
| Operating Income | -$2.5M | +45.2% | -15.7% |
| Pre-tax Income | -$2.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $422K | -57.4% | — |
| Accounts Receivable | $83K | +175.0% | — |
| Current Assets | $6.0M | +62.1% | +339.0% |
| Total Assets | $14.2M | +16.3% | +58.3% |
| Current Liabilities | $2.7M | -39.5% | -21.4% |
| Long-term Debt | $150K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.9M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $11.3M | — | — |
| -58.5% |
| Income Tax | $0 | — | — |
| Net Income | -$2.9M | +33.1% | -58.5% |
| EPS (Basic) | -$0.58 | +50.4% | -1060.0% |
| EPS (Diluted) | -$0.58 | +50.4% | -1060.0% |
| +0.0% |
| -91.2% |
| Total Liabilities | $3.3M | -36.1% | -17.8% |
| Stockholders' Equity | $10.4M | +70.0% | +114.8% |